Table 5.
Survival analysis according to neoadjuvant chemotherapy
| Variable | DFS |
OS |
||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Treatment (before matching) | ||||
| Neoadjuvant chemotherapy | Reference | Reference | ||
| Non-neoadjuvant chemotherapy | 0.54 (0.33–0.89) | 0.015 | 0.67 (0.36–1.25) | 0.210 |
| Treatment (after matching) | ||||
| Neoadjuvant chemotherapy | Reference | Reference | ||
| Non-neoadjuvant chemotherapy | 0.74 (0.42–1.28) | 0.277 | 0.87 (0.43–1.78) | 0.711 |
DFS, disease-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval.